Perspective on US Supreme court case regarding gene patenting (AMP v. Myriad), 2013.

I regularly write opinion pieces and give interviews on issues related to my research. I welcome media inquiries on a range of topics, including: genetics and biotechnology policy, science and technology policy and politics, patent law and policy, innovation and social change, bioethics, responsible innovation, and science, technology, and social justice. My work has appeared in The Conversation, The New York Times, Nature, and Issues in Science and Technology. I have been interviewed by PBS, The New Scientist, the San Diego Union Tribune, and German ARD Radio. The Women’s Media Center has listed me as a SheSource expertFor media inquiries, please contact me via email.

For a full list of media appearances, please see my CV.


Selected Op-Eds and Other Media Pieces:

Shobita Parthasarathy. “Use the Patent System to Regulate Gene Editing.” Nature. 25 October 2018.

Shobita Parthasarathy. “How to make sure we all benefit when nonprofits patent technologies like CRISPR.” The Conversation.  July 19, 2017.

Shobita Parthasarathy, “Obama administration’s big science and tech innovation: Socially engaged policy.” The Conversation. December 19, 2016.

Shobita Parthasarathy, “Fostering Grassroots Innovation: Lessons India Can Teach Michigan.” The Next Idea, Stateside, Michigan Radio. May 9, 2016. Op-ed and radio interview.

Shobita Parthasarathy, "CRISPR Dispute Raises Bigger Patent Issues We're Not Talking About." The Conversation. April 4, 2016.

Shobita Parthasarathy, “Awash in pink, but breast cancer awareness isn’t a cure.” The Conversation. Updated Version published October 15, 2015.

Shobita Parthasarathy, “An early expression of democracy, the US patent system is out of step with today’s citizens.” The Conversation. July 31, 2015.

Shobita Parthasarathy, “Ownership of Genes Stops Research”. In, Room for Debate: Can the Human Blueprint Have Owners?. The New York Times. June 7, 2013.

Shobita Parthasarathy, “Patents will Shape Geoengineering R&D.” Response to K. Caldeira and D. Keith, “The Need for Climate Engineering Research.” Issues in Science and Technology. Winter 2011.

Shobita Parthasarathy, “Gene Patents and Democracy,” Nature, 2011.


Radio and Podcast Interviews:

"Patent Politics" Tech Talk, Center for Democracy and Technology, March 30, 2017. 

Fostering Grassroots Innovation: Lessons India Can Teach Michigan.” The Next Idea, Stateside, Michigan Radio. May 9, 2016. Op-ed and radio interview.

“Central Time” discussion on gene patenting, Wisconsin Public Radio, June 14, 2013.

Silke Hasselman. “USA-Biotech Justizministerium will Gen-Patentierung stark einschränken.” German ARD (Public) Radio. November 5, 2010.

"Gene Patenting." Panel discussion with Shobita Parthasarathy, Joshua Sarnoff, and Hans Sauer. The Kojo Nnamdi Show. WAMU Radio (Washington, DC). June 4, 2009.


Selected Media Mentions:

Diana Crow, “Silicon Valley Meets Biomedical Research in the Chan Zuckerberg Initiative.” Cell. Vol. 169, Issue 5, p. 767-769.

CJ Arlotta. "Britain's Best Option to Undo Brexit." Yahoo Finance. July 1, 2016. Reprinted in The Fiscal Times.

Ian Dillingham. “Proposed genetic research moratorium raises ethical considerations, but unlikely to impact University projects.” The Michigan Daily. March 22, 2015.

Katelyn Feral. “Komen acceptance of drilling-linked money raises ire.” Pittsburgh Tribune. October 25, 2014.

Richard Wolf. “Justices rule human genes cannot be patented.” USA Today. June 13, 2013.

Amy Maxmen. “Are Gene Patents Standing in the Way of Personalized Medicine?PBS NOVAnext.. March 19 2013.

Daniel Cressey. “Cancelled project spurs debate over geoengineering patents.” Nature. May 23 2012.